Trials / Unknown
UnknownNCT00780429
Pharmacokinetics and Pharmacodynamics of MPA in Stable Renal Transplant Patients
Evaluation of Pharmacokinetic and Pharmacodynamic Parameters in Renal Transplant Patients Receiving Mycophenolic Acid and Stable for at Least 3 Months
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 54 (actual)
- Sponsor
- Fondazione IRCCS Policlinico San Matteo di Pavia · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Study of the pharmacokinetic and pharmacodynamic variability of mycophenolate mofetil in renal transplant patients already on long-term MMF treatment (at least 6 months post-transplant; at least 3 months in therapy). Study hypothesis: to investigate whether long-term MMF therapy alters IMPDH biological activity and if there are any correlations with the risk of AR.
Conditions
Timeline
- Start date
- 2006-06-01
- First posted
- 2008-10-27
- Last updated
- 2008-10-27
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT00780429. Inclusion in this directory is not an endorsement.